Frontiers in Pharmacology (Aug 2023)

Mechanism of Qingchang Suppository on repairing the intestinal mucosal barrier in ulcerative colitis

  • Jingyi Shan,
  • Jingyi Shan,
  • Suxian Liu,
  • Suxian Liu,
  • Haoyue Liu,
  • Jianye Yuan,
  • Jiang Lin

DOI
https://doi.org/10.3389/fphar.2023.1221849
Journal volume & issue
Vol. 14

Abstract

Read online

Ulcerative colitis (UC) is a refractory inflammatory bowel disease, and the outcomes of conventional therapies of UC, including 5-aminosalicylic acid, glucocorticoids, immunosuppressants, and biological agents, are not satisfied with patients and physicians with regard to adverse reactions and financial burden. The abnormality of the intestinal mucosal barrier in the pathogenesis of UC was verified. Qingchang Suppository (QCS) is an herbal preparation and is effective in treating ulcerative proctitis. The mechanism of QCS and its active ingredients have not been concluded especially in mucosal healing. This review elucidated the potential mechanism of QCS from the intestinal mucosal barrier perspective to help exploring future QCS research directions.

Keywords